1Califf RM,Holman R.Navigator Trial Steering Committee and Investigators.People at increased risk of cardiovascular disease screened for the NAVIGATOR trial frequently have undiagnesed diabetes or impaired glucose tolerance.J Am Coll Cardiol,2003,41 (Suppl A):530A-531A.
2Bartnik M,Malmberg K,Hamsten A,et al.Abnormal glucose tolerance-a common risk factor in patients with acute myocardial infarction in comparison with population-based controls.J Intern Med,2004,256:288-297.
3Hu DY,Pan CY,Yu JM,et al.The relationship between coronary artery disease and abnormal glucose regulation in China:the China Heart Survey.Eur Heart J,2006,27:2573-2579.
4Nakagami T.Hyperglycaemia and mortality from all causes and from cardiovascular disease in five populations of Asian origin.Diabetologia,2004,47:385-394.
5The ACCORD study Group.The Action to Control Cardiovascular Risk in Diabetes Study Group.Effects of intensive glucose lowering in type 2 diabetes.N Engl J Med,2008,358-2545-2559.
6The ADVANCE Collaborative Group.Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes.N Engl J Med,2008,358:2560-2572.
7Duckworth W,Abraira C,Moritz T,et al.For the VADT Investigators.Glucose Control and Vascular Complications in Veterans with Type 2 Diabetes.N Engl J Med,2009,360:129-139.
8Holman RR,Paul SK,Bethel MA,et al.10-year follow-up of intensive glucose control in type 2 diabetes.N Engl J Meat,2008,359:1577-1589.
